A case report and a study of in-vitro activity suggest that tigecycline may have a role in the treatment of severe skin and soft tissue infection caused by Vibrio vulnificus.[60]Tang H, Chen C, Lai C, et al. In vitro and in vivo antibacterial activity of tigecycline against Vibrio vulnificus. J Microbiol Immunol Infect. 2018;51:76-81.
https://www.e-jmii.com/article/S1684-1182(16)30039-1/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/27260781?tool=bestpractice.com
[61]Lin Y, Hung M, Chen C, et al. Tigecycline salvage therapy for necrotizing fasciitis caused by Vibrio vulnificus: case report in a child. J Microbiol Immunol Infect. 2016;49:138-41.
https://www.e-jmii.com/article/S1684-1182(13)00077-7/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/23751766?tool=bestpractice.com